- Motley Fool•9 minutes ago
The market for multiple sclerosis drugs is worth billions of dollars every year and these are the companies that benefit most.
- Zacks•14 hours ago
Roche Holding (RHHBY) reported sales of $12.1 billion in the second quarter of 2016, missing the Zacks Consensus Estimate of $12.9 billion.
|52wk Range||29.89 - 36.49|
|Day's Range||31.38 - 31.61|
|Avg Vol (3m)||1,002,433|
As of 4:00 PM EDT. Market closed.